James L. Tyree, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 33,642 shares at $55.30 ($1.9M) on 2009-02-02, disclosed to the SEC on 2009-02-18.
Scheduled sale ($1.9M) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.88 | 1,000 | $55K | 3.0% |
| 2 | $55.20 | 1,000 | $55K | 3.0% |
| 3 | $55.21 | 4,800 | $265K | 14.3% |
| 4 | $55.22 | 4,300 | $237K | 12.8% |
| 5 | $55.23 | 2,400 | $133K | 7.1% |
| 6 | $55.24 | 500 |
| $28K |
| 1.5% |
| 7 | $55.25 | 1,400 | $77K | 4.2% |
| 8 | $55.26 | 1,500 | $83K | 4.5% |
| 9 | $55.27 | 1,200 | $66K | 3.6% |
| 10 | $55.28 | 3,100 | $171K | 9.2% |
| 11 | $55.29 | 3,000 | $166K | 8.9% |
| 12 | $55.30 | 1,000 | $55K | 3.0% |
| 13 | $55.32 | 1,642 | $91K | 4.9% |
| 14 | $55.33 | 5,300 | $293K | 15.8% |
| 15 | $55.34 | 1,500 | $83K | 4.5% |
| Total | $55.26 avg | 33,642 | $1.9M | 100% |
| Filing → |
| ASRT | SELL | 2024-03-15 | $11K | — | Filing → |
| GNLX | SELL | 2023-12-14 | $192K | — | Filing → |
| ASRT | SELL | 2023-05-05 | $259K | — | Filing → |